Marpai Inc. (MRAI) Insider Trading

Last 12 months

Insiders bought $203k on the open market and sold nothing.

Net open-market

+$203k

5 buys · 0 sales

Under a 10b5-1 plan

—

no sales

Insiders who bought / sold

4 / 0

executives and directors

Last open-market buy

Jun 2026

Jun 2, 2026

Get an email when MRAI's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Jun 2	Steve Andrew Johnson Chief Financial Officer	Bought	1,100	$0.62	$682	0.1%	Form 4
May 20	Yaron Eitan Director	Bought	10,000	$0.27	$3k	0.9%	Form 4
Nov 7, 2025	Yaron Eitan Director	Bought	100,000	$1.00	$100k	10%	Form 4
Nov 7, 2025	Sagiv Shiv Director	Bought	50,000	$1.00	$50k	23%	Form 4
Nov 7, 2025	Robert M Pons Director	Bought	50,000	$1.00	$50k	16%	Form 4
Aug 13, 2025 – Oct 6, 2025	Ian J. Cassel Large holder	SoldNo plan 12 parts	188,000	$1.44 average	$271k	5.0%	Form 4
Sep 30, 2025	Damien Lamendola Chief Executive Officer	Bought	147,058	$1.36	$200k	1.8%	Form 4
Sep 10, 2025	Damien Lamendola Chief Executive Officer	Bought	896,903	$1.06	$951k	13%	Form 4
Jul 29, 2025	Damien Lamendola Chief Executive Officer	Bought	371,470	$1.08	$401k	5.5%	Form 4
Jul 17, 2025	Damien Lamendola Chief Executive Officer	Bought	86,805	$1.15	$100k	1.3%	Form 4
Dec 5, 2024	John Paul Powers President and COO	Bought	10,000	$1.13	$11k	4.0%	Form 4
Dec 5, 2024	Steve Andrew Johnson Chief Financial Officer	Bought	5,000	$1.13	$6k	1.1%	Form 4
Dec 5, 2024	Yaron Eitan Director	Bought	110,619	$1.13	$125k	16%	Form 4

Jun 2
Steve Andrew Johnson
Chief Financial Officer · bought 1,100 at $0.62
$682
0.1% of stake
May 20
Yaron Eitan
Director · bought 10,000 at $0.27
$3k
0.9% of stake
Nov 7, 2025
Yaron Eitan
Director · bought 100,000 at $1.00
$100k
10% of stake
Nov 7, 2025
Sagiv Shiv
Director · bought 50,000 at $1.00
$50k
23% of stake
Nov 7, 2025
Robert M Pons
Director · bought 50,000 at $1.00
$50k
16% of stake
Aug 13, 2025 – Oct 6, 2025No plan
Ian J. Cassel
Large holder · sold 188,000 at avg $1.44
$271k
5.0% of stake
Sep 30, 2025
Damien Lamendola
Chief Executive Officer · bought 147,058 at $1.36
$200k
1.8% of stake
Sep 10, 2025
Damien Lamendola
Chief Executive Officer · bought 896,903 at $1.06
$951k
13% of stake
Jul 29, 2025
Damien Lamendola
Chief Executive Officer · bought 371,470 at $1.08
$401k
5.5% of stake
Jul 17, 2025
Damien Lamendola
Chief Executive Officer · bought 86,805 at $1.15
$100k
1.3% of stake
Dec 5, 2024
John Paul Powers
President and COO · bought 10,000 at $1.13
$11k
4.0% of stake
Dec 5, 2024
Steve Andrew Johnson
Chief Financial Officer · bought 5,000 at $1.13
$6k
1.1% of stake
Dec 5, 2024
Yaron Eitan
Director · bought 110,619 at $1.13
$125k
16% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch MRAI, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Related stocks: Services-Misc Health & Allied Services, NEC

OTRKQOntrak Inc.

PFHOPacific Health Care Organization Inc.

NIVFNewGenIvf Group Limited

CCELCryo-Cell International Inc.

EHSIElite Health Systems Inc

GRSTEthema Health Corporation

VSEEVsee Health Inc.

PMDIPsychemedics Corp.

Spot a number that looks wrong? Check it in MRAI's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing MRAI

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.